SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by CDK4/6 inhibitors

Autor: Cui, Yingshu, Li, Yi, Xu, Yuanyuan, Liu, Xinxin, Kang, Xiaofeng, Zhu, Junwen, Long, Shan, Han, Yuchen, Xue, Chunyuan, Sun, Zhijia, Du, Yimeng, Hu, Jia, Pan, Lu, Zhou, Feifan, Xu, Xiaojie, Li, Xiaosong

Publikováno v: In Redox Biology October 2024 76

FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect

Autor: Chu, Zhong, Huo, Nan, Zhu, Xiang, Liu, Hanxiao, Cong, Rui, Ma, Luyuan, Kang, Xiaofeng, Xue, Chunyuan, Li, Jingtong, Li, Qihong, You, Hua, Zhang, Qingyuan, Xu, Xiaojie

Publikováno v: In Molecular Therapy 1 September 2021 29(9):2737-2753

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination.

Autor: Sun Z; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China.; Department of Radiation Oncology, Air Force Medical Center PLA, Air Force Medical University, Beijing, China., Mai H; Department of Urology, the Third Medical Center of PLA General Hospital, Beijing, China., Xue C; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China., Fan Z; Department of Biotherapy Center, Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China., Li J; Bioinformatics Center of Academy of Military Medical Sciences, Beijing, China., Chen H; Department of Urology, the Third Medical Center of PLA General Hospital, Beijing, China., Huo N; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China., Kang X; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China., Tang C; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China., Fang L; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China., Zhao H; Department of Oncology, Chinese PLA General Hospital Fifth Medical Center, Beijing, China., Han Y; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China., Sun C; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China., Peng H; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China., Du Y; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China miraclexxj@126.com dunan05@aliyun.com yangjing_301@126.com duyimeng1987@163.com., Yang J; Department of Oncology, Chinese PLA General Hospital Second Medical Center, Beijing, China miraclexxj@126.com dunan05@aliyun.com yangjing_301@126.com duyimeng1987@163.com., Du N; Department of Oncology, Chinese PLA General Hospital Fifth Medical Center, Beijing, China miraclexxj@126.com dunan05@aliyun.com yangjing_301@126.com duyimeng1987@163.com., Xu X; Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China miraclexxj@126.com dunan05@aliyun.com yangjing_301@126.com duyimeng1987@163.com.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Dec 01; Vol. 11 (12). Date of Electronic Publication: 2023 Dec 01.